Dr. Albitar on the Importance of Obtaining Genomic Testing in Oncology

Video

Maher Albitar, MD, discusses the importance of obtaining genomic testing in oncology.

Maher Albitar, MD, founder, chief executive office, chief medical officer, Genomic Testing Cooperative, discusses the importance of obtaining genomic testing in oncology.

Obtaining genomic information in oncology can inform a patient’s diagnosis, Albitar says. Moreover, genomic testing can help in understanding complicated disease presentations.

Additionally, genomic information can provide insight into a patient’s prognosis, treatment selection, long-term management strategies, minimal residual disease, comorbidity factors, and the risk of adverse effects of therapy, Albitar explains. Ultimately, obtaining genomic testing can help to guide providers and patients through common challenges encountered during the patient’s disease course and cancer treatment journey, Albitar concludes.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,